WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001005385) NEW USE OF A MACROLIDE COMPOUND FOR TREATING NEURODEGENERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/005385 International Application No.: PCT/GB2000/002788
Publication Date: 25.01.2001 International Filing Date: 19.07.2000
Chapter 2 Demand Filed: 07.02.2001
IPC:
A61K 31/436 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
436
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
Applicants: JONES, Paul, Alexander[GB/GB]; GB (UsOnly)
SHARKEY, John[GB/GB]; GB (UsOnly)
KELLY, John, Shearer[GB/GB]; GB (UsOnly)
FUJISAWA PHARMACEUTICAL CO LTD[JP/JP]; 4-7, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-8514, JP (AllExceptUS)
Inventors: JONES, Paul, Alexander; GB
SHARKEY, John; GB
KELLY, John, Shearer; GB
Agent: GAUNT, Robert, John ; Stevens Hewlett & Perkins Halton House 20/23 Holborn London, Greater London EC1N 2JD, GB
Priority Data:
9917158.921.07.1999GB
Title (EN) NEW USE OF A MACROLIDE COMPOUND FOR TREATING NEURODEGENERATIVE DISORDERS
(FR) NOUVELLE UTILISATION D'UN COMPOSE DE MACROLIDE
Abstract:
(EN) Macrolide compound, such as a tacrolimus analogue is provided for use as a neuroprotective agent, particularly, for preventing or treating acute or chronic cerebral neurodegenerative diseases.
(FR) L'invention concerne un composé de macrolide, par exemple un analogue de tacrolimus, utilisé comme agent neuroprotecteur, en particulier dans la prévention ou le traitement de maladies neurodégénératives cérébrales aigües ou chroniques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)